EJEvelien A. G. Joosten

Evelien A. G. Joosten

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Evelien A. G. Joosten has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Monitoring arts and psychomotor therapies: Further development and validation of the Self-expression and Emotion-Regulation in Arts and Psychomotor Therapies Scale (SERAPTS)

    by Suzanne Haeyen, Eric Noorthoorn, Evelien Joosten

    Background: The present study is an extension of previous research, which resulted in the development of a valid, reliable and user-friendly tool for monitoring art therapy. The purpose of this study was to examine the extended reliability and sensitivity to change of the adapted version of the above scale, now called the Self-expression and Emotion Regulation in Arts and Psychomotor Therapies Scale (SERAPTS) for art, dance, drama, music and psychomotor therapy. Methods: A pre-post design study was conducted on adult patients diagnosed with emotion regulation problems or personality disorder(s) cluster B/C. The study’s sample size was determined by the researchers to be 96 participants for the purpose of testing internal consistency, and 67 participants for the purpose of testing sensitivity for change. Results: An excellent internal consistency was found for all domains of therapy combined (Cronbach’s α =  0.95). Additionally, high to excellent internal consistencies were identified for dance ( α =  0.88), drama ( α =  0.89), music ( α =  0.95), and psychomotor therapy ( α =  0.95), when considered separately. Furthermore, a significant sensitivity for change was identified within a 3-month timeframe (t = −4.39, p < .001), accompanied by a medium effect size (Cohen’s d =  0.54). Discussion: The validity of the tool has been established in previous research. The present study sought to establish the applicability and reliability/sensitivity to change of the SERAPTS, with a view to extending it to the broad spectrum of all creative arts and psychomotor therapies. The SERAPTS was shown to be a valid and sensitive instrument for monitoring the effects of creative arts and psychomotor therapies, indicating healthy self-expression and emotion regulation skills that serve positive self-regulation.


  • Open Access

    Forcibly displaced adults' perspectives on change mechanisms after a resilience-building art therapy intervention

    by Natacha Pirotte, Liliana Montoya De La Cruz, Viviana Rodriguez Gonzalez, Martina de Witte, Evelien Joosten


  • Shared Decision-Making: van RCT naar praktijk

    by Evelien A.G. Joosten, Boukje A.G. Dijkstra, Cor A.J. de Jong


  • A family history of alcoholism relates to alexithymia in substance use disorder patients

    by Hein A. de Haan, Evelien A.G. Joosten, Lydia de Haan, Arnt F.A. Schellekens, Jan K. Buitelaar, Job van der Palen, Cor A.J. De Jong


  • Alexithymia is not a stable personality trait in patients with substance use disorders

    by Hein de Haan, Evelien Joosten, Toon Wijdeveld, Peter Boswinkel, Job van der Palen, Cor De Jong


  • Shared Decision-Making: Increases Autonomy in Substance-Dependent Patients

    by Evelien A. G. Joosten, Cor A. J. De Jong, Gerdien H. de Weert-Van Oene, Tom Sensky, Cees P. F. van der Staak

    This study examines the effect of a shared decision-making intervention (SDMI) on patients’ and clinicians’ self-perceived interpersonal behavior. Clinicians (n = 34) in three addiction treatment centers in the Netherlands were randomly assigned to SDMI or treatment decision-making as usual. Patients receiving inpatient treatment in 2005–2006 were included (n = 212). Baseline characteristics were measured by the European Addiction Severity Index (EuropASI) and the Composite International Diagnostic Interview—Substance Abuse Module (CIDI-SAM). Treatment goals were assessed using the Goals of Treatment Questionnaire (GoT-Q) plus a Q-sort ranking procedure. Interpersonal behavior was measured by Interpersonal Checklist—Revised (ICL-R) at baseline, end of treatment, and 3-month follow-up. Repeated measures analyses of variance and multiple hierarchical linear regression analysis were used. The key finding of this study was that SDMI is associated with an increase of patient autonomy (independent behavior) and control behavior. The study limitations have been noted. Prise de decision partagée: Augmente l'autonomie des patients dependant aux substances Cette étude examine les effets de l'intervention basée sur la prise de décision partagée (SDMI) sur les comportements inter-personnels auto-perçus par les patients et les cliniciens. Des cliniciens (n = 34) de trois centres de traitement en Hollande ont été répartis de manière aléatoire dans le groupe SDMI ou le groupe prise de décision thérapeutique habituelle. Les patients admis pour traitement non-ambulatoire entre 2005–2006 ont été inclus (n = 212). Les caractéristiques de base ont été évaluées par le biais du European Addiction Severity Index (EuropASI) et le Composite International Diagnostic Interview –Substance abuse module (CIDI-SAM). Les objectifs thérapeutiques ont été évalués par le biais du Goals of Treatment Questionnaire (GoT-Q) et d'une procédure de classification de type Q-sort. Les comportements interpersonnels ont été mesures par la Interpersonnal Checklist-Revised (ICL-R) à l'admission dans l’étude, la fin du traitement et après trois mois de suivi. Des analyses de variances sur mesures répétées, ainsi qu'une analyse de régression linéaire multiple hiérarchique, ont été utilisées. Le résultat clé de cette étude est que la SDMI est associée avec une amélioration de l'autonomie du patient (comportement indépendant) et du comportement contrôle. Les limitations de cette étude sont également discutées. La Toma de decisiones compartida: Aumenta la autonomía de los pacientes dependientes de sustancias Este estudio examina el efecto de una intervención de toma de decisiones compartidas (shared decision-making intervention –SDMI) en el comportamiento de auto-percepción interpersonal entre pacientes y profesionales de la salud. Los profesionales de la salud (n = 34) fueron reclutados en tres centros especialiazados en el tratamiento de adicciones en los Países Bajos, estos fueron asignados aleatoriamente a la intervención de toma de decisiones compartida (SDMI) o al tratamiento usual de toma de decisiones. Todos los pacientes (n = 212) que recibieron tratamiento hospitalario en el período 2005–2006 fueron incluidos en este estudio. Las variables fueron medidas por el Índice Europeo de Severidad de la Adicción (EuropASI) y la Entrevista Diagnóstica Internacional Compuesta –Módulo de Abuso de Sustancias (CIDI-SAM). Los objetivos del tratamiento se evaluaron utilizando el Cuestionario de Objetivos del Tratamiento (Goals of Treatment Questionnaire GoT-Q) y de un procedimiento de ranking (Q-sort ranking). La conducta interpersonal se evaluó con la Lista Interpersonal Revisada (Interpersonal Checklist Revised, ICL-R) al inicio del estudio, al final del tratamiento, y 3 meses después de la finalización del mismo. Análisis de varianza con medidas repetidas y regresión lineal múltiple (modelo jerárquico) fueron aplicados. La conclusión principal de este estudio es que la intervención toma de decisiones compartida (SDMI) se asocia con un aumento de la autonomía del paciente (comportamiento independiente) y el comportamiento de control. Las limitaciones de este estudio son tomadas en consideración en este artículo.


  • Cognitive Behavioural Treatment Is as Effective in High- as in Low-Scoring Alexithymic Patients with Substance-Related Disorders

    by H.A. de Haan, E.A.G. Joosten, A.G.M. Wijdeveld, P.B. Boswinkel, J. van der Palen, C.A.J. De Jong


  • Treatment Goals in Addiction Healthcare: the Perspectives of Patients and Clinicians

    by E.A.G. Joosten, G.H. De Weert-Van Oene, T. Sensky, C.P.F. Van Der Staak, C.A.J. De Jong

    Background: Little is known about the perspectives of either patients or clinicians regarding treatment goals in addiction healthcare. In general, treatment goals involve abstinence or at least reduction of substance use.


  • Shared Decision-Making Reduces Drug Use and Psychiatric Severity in Substance-Dependent Patients

    by E.A.G. Joosten, C.A.J. de Jong, G.H. de Weert-Van Oene, T. Sensky, C.P.F. van der Staak

    Background: In the last decades, shared decision-making (SDM) models have been developed to increase patient involvement in treatment decisions. The purpose of this study was to evaluate a SDM intervention (SDMI) for patients dependent on psychoactive substances in addiction health care programs. The intervention consisted of a structured procedure to reach a treatment agreement and comprised 5 sessions. Methods: Clinicians in 3 treatment centres in the Netherlands were randomly assigned to the SDMI or a standard procedure to reach a treatment agreement. Results: A total of 220 substance-dependent patients receiving inpatient treatment were randomised either to the intervention (n = 111) or control (n = 109) conditions. Reductions in primary substance use (F(1, 124) = 248.38, p < 0.01) and addiction severity (F(8) = 27.76, p < 0.01) were found in the total population. Significant change was found in the total population regarding patients’ quality of life measured at baseline, exit and follow-up (F(2, 146) = 5.66, p < 0.01). On the European Addiction Severity Index, SDMI showed significantly better improvements than standard decision-making regarding drug use (F(1, 164) = 7.40, p < 0.01) and psychiatric problems (F(1, 164) = 5.91, p = 0.02) at 3-month follow-up. Conclusion: SDMI showed a significant add-on effect on top of a well-established 3-month inpatient intervention. SDMI offers an effective, structured, frequent and well-balanced intervention to carry out and evaluate a treatment agreement.


  • Top Cited Papers

    Systematic Review of the Effects of Shared Decision-Making on Patient Satisfaction, Treatment Adherence and Health Status

    by E.A.G. Joosten, L. DeFuentes-Merillas, G.H. de Weert, T. Sensky, C.P.F. van der Staak, C.A.J. de Jong

    Background: In the last decade, the clinician-patient relationship has become more of a partnership. There is growing interest in shared decision-making (SDM) in which the clinician and patient go through all phases of the decision-making process together, share treatment preferences, and reach an agreement on treatment choice. The purpose of this review is to determine the extent, quality, and consistency of the evidence about the effectiveness of SDM. Method: This is a systematic review of randomised controlled trials (RCTs) comparing SDM interventions with non-SDM interventions. Eleven RCTs met the required criteria, and were included in this review. Results: The methodological quality of the studies included in this review was high overall. Five RCTs showed no difference between SDM and control, one RCT showed no short-term effects but showed positive longer-term effects, and five RCTs reported a positive effect of SDM on outcome measures. The two studies included of people with mental healthcare problems reported a positive effect of SDM. Conclusions: Despite the considerable interest in applying SDM clinically, little research regarding its effectiveness has been done to date. It has been argued that SDM is particularly suitable for long-term decisions, especially in the context of a chronic illness, and when the intervention contains more than one session. Our results show that under such circumstances, SDM can be an effective method of reaching a treatment agreement. Evidence for the effectiveness of SDM in the context of other types of decisions, or in general, is still inconclusive. Future studies of SDM should probably focus on long-term decisions.